Treasury Board of Canada Secretariat
Symbol of the Government of Canada

ARCHIVED - Patented Medicine Prices Review Board Canada

Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.





2010-11
Report on Plans and Priorities



Patented Medicine Prices Review Board Canada






Supplementary Information (Tables)






Table of Contents




Green Procurement

Part A: Green Procurement Capacity Building



Activity 2009-2010
Level
as %
2010-11
Target
as %
Description/Comments
1a. Training for Procurement and Materiel Management Staff 0% 25% As a micro-organization, the Patented Medicine Prices Review Board (PMPRB) does not have full FTEs dedicated to Procurement and/or Materiel Management. However, training will be provided to a staff member responsible for these activities.
1b.Training for Acquisition Cardholders 0% 50% 50% of the acquisition cardholders will receive training.
2.Performance Evaluations 0% 100% The PMPRB does not have managers/functional heads of procurement, However, the tracking of green procurement performance will be considered in the relevant managers' performance.
3. Procurement Processes and Controls     The PMPRB, as a small agency, takes advantage of the guidance and procurement instruments provided by Public Works and Government Services Canada. As such, the use of standing offers ensures that environmental attributes of suppliers are considered. During the course of a major retrofit in 2008-2009, the PMPRB had the opportunity to incorporate green principles, such as motion sensor lights in meeting rooms and green procured furniture, into their renovated facilities. In 2010-2011, the PMPRB will review all procurement with a view to using green consolidated procurement instruments.


Part B: Use of Green Consolidated Procurement Instruments



Good/Sevice 2009-2010
Level as
2010-11
Target
as %
Description/Comments
$ %
IT Hardware Data not available   25% The PMPRB will improve the tracking and monitoring of the use of green consolidated procurement instruments.
Paper Data not available   80%  
Printer toners Data not available   50%  




Upcoming Evaluations (Next three fiscal years)



Name of Evaluation Program Type Status Expected Completion Date
Evaluation of the Compliance and Enforcement Program Regulation of the prices of patented drug products (core program) Planned March 31, 2012



Sources Non-Respendable Revenue



Sources of Non-Respendable Revenue
($ thousands)
Program Activity Forecast
Revenue
2009-10
Planned
Revenue
2010-11
Planned
Revenue
2011-12
Planned
Revenue
2012-13
Compliance and enforcement of non-excessive pricing for patented medicines 28,372.91,2 - - -
Total Non-respendable Revenue 28,372.9 - - -



1The money reported as non-respendable revenue does not represent revenues generated by the PMPRB. This money is a result of payments made by patentees to the Government of Canada through Voluntary Compliance Undertakings (VCUs) or Board orders to offset excess revenues. The Minister may enter into agreements with any province or territory respecting the distribution to that province/territory of amounts received by the Receiver General, less any costs incurred in relation to the collection and distribution of those amounts.

2A Federal Court decision in the matter of Teva Neuroscience G.P. - S.E.N.C. v. Attorney General of Canada ordered the repayment of the sum of $2,417,.2 million, paid by Teva to the Consolidated Revenue Fund, be returned to Teva.